CellBion Co., Ltd. (KOSDAQ:308430)
South Korea flag South Korea · Delayed Price · Currency is KRW
28,100
-300 (-1.06%)
At close: Aug 26, 2025, 3:30 PM KST

CellBion Statistics

Total Valuation

CellBion has a market cap or net worth of KRW 349.31 billion. The enterprise value is 323.58 billion.

Market Cap349.31B
Enterprise Value 323.58B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

CellBion has 12.82 million shares outstanding.

Current Share Class 12.82M
Shares Outstanding 12.82M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 36.45%
Owned by Institutions (%) 3.59%
Float 8.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 132.89
PB Ratio 13.24
P/TBV Ratio 13.56
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -43.55
EV / Sales 123.10
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -50.63

Financial Position

The company has a current ratio of 28.47, with a Debt / Equity ratio of 0.10.

Current Ratio 28.47
Quick Ratio 27.82
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF -0.40
Interest Coverage -72.31

Financial Efficiency

Return on equity (ROE) is -48.16% and return on invested capital (ROIC) is -26.56%.

Return on Equity (ROE) -48.16%
Return on Assets (ROA) -22.90%
Return on Invested Capital (ROIC) -26.56%
Return on Capital Employed (ROCE) -24.81%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.13
Inventory Turnover 3.16

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 24,816.40
200-Day Moving Average 18,196.35
Relative Strength Index (RSI) 53.97
Average Volume (20 Days) 227,104

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CellBion had revenue of KRW 2.63 billion and -7.43 billion in losses.

Revenue2.63B
Gross Profit 1.02B
Operating Income -7.65B
Pretax Income -7.43B
Net Income -7.43B
EBITDA -7.00B
EBIT -7.65B
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 28.29 billion in cash and 2.55 billion in debt, giving a net cash position of 25.73 billion or 2,007.55 per share.

Cash & Cash Equivalents 28.29B
Total Debt 2.55B
Net Cash 25.73B
Net Cash Per Share 2,007.55
Equity (Book Value) 26.39B
Book Value Per Share n/a
Working Capital 28.53B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.15 billion and capital expenditures -238.52 million, giving a free cash flow of -6.39 billion.

Operating Cash Flow -6.15B
Capital Expenditures -238.52M
Free Cash Flow -6.39B
FCF Per Share -498.56
Full Cash Flow Statement

Margins

Gross margin is 38.79%, with operating and profit margins of -290.98% and -282.69%.

Gross Margin 38.79%
Operating Margin -290.98%
Pretax Margin -282.69%
Profit Margin -282.69%
EBITDA Margin -266.20%
EBIT Margin -290.98%
FCF Margin n/a

Dividends & Yields

CellBion does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -2.13%
FCF Yield -1.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CellBion has an Altman Z-Score of 21.29 and a Piotroski F-Score of 3.

Altman Z-Score 21.29
Piotroski F-Score 3